Overview
FLuorescence Cholangiography Using Methylene Blue
Status:
Unknown status
Unknown status
Trial end date:
2018-06-01
2018-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Open label prospective, non-randomised proof of principle study assessing the use of methylene blue fluorescence cholangiography.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of OxfordCollaborator:
Oxford University Hospitals NHS TrustTreatments:
Methylene BlueCriteria
Inclusion Criteria:- Participant is willing and able to give informed consent for participation in the
study.
- Male or Female, aged 18 years or above.
- Undergoing laparoscopic cholecystectomy
Exclusion Criteria:
- Patient who is unable or unwilling to give informed consent
- Known allergy to methylene blue
- Risk of serotonin syndrome (taking SSRI / G6PD deficiency / previous serotonin
syndrome)
- Significant renal failure
- Pregnant / planning pregnancy or breastfeeding